Trial intelligence / Profile preview

Intrathecal enzyme replacement therapy for spinal cord compression in mucopolysaccharidosis I (MIRC-001)

2006-005216-27Phase 4Completed

Sponsor
Helsinki University Hospital
Start
Mar 2007
Modality
Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, single-arm trial of laronidase in mucopolysaccharidosis type I, sponsored by Helsinki University Hospital. Started Mar 2007; status: completed.

02

Drugs

laronidase
03

Conditions

mucopolysaccharidosis type I

Beyond the preview

Go deeper on 2006-005216-27.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-005216-27.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call